BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gambara G, Gaebler M, Keilholz U, Regenbrecht CRA, Silvestri A. From Chemotherapy to Combined Targeted Therapeutics: In Vitro and in Vivo Models to Decipher Intra-tumor Heterogeneity. Front Pharmacol 2018;9:77. [PMID: 29491834 DOI: 10.3389/fphar.2018.00077] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 3.5] [Reference Citation Analysis]
Number Citing Articles
1 Pfohl U, Pflaume A, Regenbrecht M, Finkler S, Graf Adelmann Q, Reinhard C, Regenbrecht CRA, Wedeken L. Precision Oncology Beyond Genomics: The Future Is Here-It Is Just Not Evenly Distributed. Cells 2021;10:928. [PMID: 33920536 DOI: 10.3390/cells10040928] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
2 An JH, Song WJ, Li Q, Bhang DH, Youn HY. 3D-culture models as drug-testing platforms in canine lymphoma and their cross talk with lymph node-derived stromal cells. J Vet Sci 2021;22:e25. [PMID: 33908202 DOI: 10.4142/jvs.2021.22.e25] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
3 Silvestri A, Vicente F, Vicent MJ, Stechmann B, Fecke W. Academic collaborative models fostering the translation of physiological in vitro systems from basic research into drug discovery. Drug Discov Today 2021;26:1369-81. [PMID: 33677144 DOI: 10.1016/j.drudis.2021.02.024] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
4 Lyubitelev AV, Kirpichnikov MP, Studitsky VM. The Role of Linker Histones in Carcinogenesis. Russ J Bioorg Chem 2021;47:278-287. [DOI: 10.1134/s1068162021010143] [Reference Citation Analysis]
5 Gottlieb B, Trifiro M, Batist G. Why Tumor Genetic Heterogeneity May Require Rethinking Cancer Genesis and Treatment. Trends Cancer 2021;7:400-9. [PMID: 33243702 DOI: 10.1016/j.trecan.2020.10.013] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
6 Song H, Cai GH, Liang J, Ao DS, Wang H, Yang ZH. Three-dimensional culture and clinical drug responses of a highly metastatic human ovarian cancer HO-8910PM cells in nanofibrous microenvironments of three hydrogel biomaterials. J Nanobiotechnology 2020;18:90. [PMID: 32527266 DOI: 10.1186/s12951-020-00646-x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 10.5] [Reference Citation Analysis]
7 Stulpinas A, Imbrasaitė A, Krestnikova N, Valerija Kalvelytė A. Recent Approaches Encompassing the Phenotypic Cell Heterogeneity for Anticancer Drug Efficacy Evaluation. Tumor Progression and Metastasis 2020. [DOI: 10.5772/intechopen.89395] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
8 Ma C, Zhang J, Tang D, Ye X, Li J, Mu N, Li Z, Liu R, Xiang L, Huang C, Jiang R. Tyrosine Kinase Inhibitors Could Be Effective Against Non-small Cell Lung Cancer Brain Metastases Harboring Uncommon EGFR Mutations. Front Oncol 2020;10:224. [PMID: 32195178 DOI: 10.3389/fonc.2020.00224] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
9 Adishesh M, Hapangama DK. Enriching Personalized Endometrial Cancer Research with the Harmonization of Biobanking Standards. Cancers (Basel) 2019;11:E1734. [PMID: 31694311 DOI: 10.3390/cancers11111734] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
10 Bhattacharya S, Das A. Fast and robust method for drug response biomarker identification and sample stratification.. [DOI: 10.1101/525337] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
11 Patterson SE, Statz CM, Yin T, Mockus SM. Utility of the JAX Clinical Knowledgebase in capture and assessment of complex genomic cancer data. NPJ Precis Oncol 2019;3:2. [PMID: 30675517 DOI: 10.1038/s41698-018-0073-y] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 4.7] [Reference Citation Analysis]
12 Lin A, Yan WH. Heterogeneity of HLA-G Expression in Cancers: Facing the Challenges. Front Immunol 2018;9:2164. [PMID: 30319626 DOI: 10.3389/fimmu.2018.02164] [Cited by in Crossref: 82] [Cited by in F6Publishing: 85] [Article Influence: 20.5] [Reference Citation Analysis]
13 Di Liegro CM, Schiera G, Di Liegro I. H1.0 Linker Histone as an Epigenetic Regulator of Cell Proliferation and Differentiation. Genes (Basel) 2018;9:E310. [PMID: 29925815 DOI: 10.3390/genes9060310] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]